{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:25:45Z","timestamp":1789392345560,"version":"build-2803163510"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:p>Objective. Our study was designed to establish in children with asthma the safety profile of repeated short courses of oral glucocorticoids on bone mineralization and metabolism and adrenal function.<\/jats:p><jats:p>Methods. This cross-sectional study compared the bone density, bone metabolism, and adrenal function of children who were and were not exposed to bursts of oral glucocorticoids. Children were considered exposed when, in the preceding year, they received \u22652 courses of oral glucocorticoids and were prescribed the same therapy for the index exacerbation. Children were considered unexposed when they had no exposure to oral glucocorticoids and were not prescribed any for the index exacerbation. Indices of bone metabolism were measured during the subsequent month. Cortisol responses to adrenocorticotrophic hormone stimulation and bone density were assessed 30 days after the index exacerbation.<\/jats:p><jats:p>Results. Eighty-three children (48 exposed, 35 unexposed) aged 2 to 17 years were enrolled. The median exposure level was 4 courses (range: 3\u201311) in the preceding year. Among exposed children, a transient decrease in serum osteocalcin was observed at the end of the 5-day course with a return to baseline by 30 days; no change was observed in urine pyridinoline cross-links. Mean bone density z score was similar in the exposed (\u22120.61 \u00b1 1.0 [standard deviation]) and unexposed (\u22120.67 \u00b1 0.9) groups. No cases of abnormal response to adrenocorticotrophic hormone suggestive of adrenal insufficiency were documented in the exposed (95% confidence interval: 0%\u20137%) or unexposed (0%\u201310%) groups.<\/jats:p><jats:p>Conclusions. Repeated short courses of oral glucocorticoids in the treatment of asthma seem to be reasonably safe; this practice was not associated with any lasting perturbation in bone metabolism, bone mineralization, or adrenal function.<\/jats:p>","DOI":"10.1542\/peds.111.2.376","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"376-383","source":"Crossref","is-referenced-by-count":72,"title":["Safety Profile of Frequent Short Courses of Oral Glucocorticoids in Acute Pediatric Asthma: Impact on Bone Metabolism, Bone Density, and Adrenal Function"],"prefix":"10.1542","volume":"111","author":[{"given":"Francine M.","family":"Ducharme","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Epidemiology and Biostatistics, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Que\u0301bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chabot","sequence":"additional","affiliation":[{"name":"Department of Genetics, Shriners\u2019 Hospital, McGill University Health Centre, Montreal, Que\u0301bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Polychronakos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Service of Endocrinology, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Que\u0301bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Glorieux","sequence":"additional","affiliation":[{"name":"Department of Genetics, Shriners\u2019 Hospital, McGill University Health Centre, Montreal, Que\u0301bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Mazer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Allergy and Clinical Immunology, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Que\u0301bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,2,1]]},"reference":[{"key":"2021121010094566300_R1","unstructured":"Murphy S, Sheffer AL, Pauwels R. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma (97-4051, 111). Bethesda, MD: National Institutes of Health; 1997"},{"key":"2021121010094566300_R2","unstructured":"Boulet LP, Becker A, Berube D, Beveridge R, Ernst P. Canadian asthma consensus report, 1999. Can Med Assoc J.1999;161(11 suppl):S1\u2013S72."},{"key":"2021121010094566300_R3","doi-asserted-by":"crossref","unstructured":"The British guidelines on asthma management. Thorax.1997;52(suppl 1):S1\u2013S21","DOI":"10.1136\/thx.52.suppl_5.1"},{"key":"2021121010094566300_R4","doi-asserted-by":"crossref","unstructured":"Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev2000;(2):CD002178","DOI":"10.1002\/14651858.CD002178"},{"key":"2021121010094566300_R5","doi-asserted-by":"crossref","unstructured":"Boulet LP. Perception of the role and potential side effects of inhaled corticosteroids among asthmatic patients. Chest.1998;113:587\u2013592","DOI":"10.1378\/chest.113.3.587"},{"key":"2021121010094566300_R6","doi-asserted-by":"crossref","unstructured":"Crain EF, Weiss KB, Fagan MJ. Pediatric asthma care in US emergency departments. Current practice in the context of the National Institutes of Health guidelines. Arch Pediatr Adolesc Med.1995;149:893\u2013901","DOI":"10.1001\/archpedi.1995.02170210067012"},{"key":"2021121010094566300_R7","doi-asserted-by":"crossref","unstructured":"Hodgson SF. Metabolic bone disease, part II: corticosteroid-induced osteoporosis. Endocrinol Metab Clin North Am.1990;19:95\u2013111","DOI":"10.1016\/S0889-8529(18)30340-2"},{"key":"2021121010094566300_R8","unstructured":"Nielsen HK, Thomsen K, Eriksen EF, Charles P, Mosekilde L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner.1988;4:105\u2013113"},{"key":"2021121010094566300_R9","doi-asserted-by":"crossref","unstructured":"Streck WF, Lockwood HD. Pituitary recovery following short-term suppression with corticosteroids. Am J Med.1979;66:910","DOI":"10.1016\/0002-9343(79)90444-3"},{"key":"2021121010094566300_R10","doi-asserted-by":"crossref","unstructured":"Wilmsmeyer W, Ukena D, Wagner TO, Sybrecht GW. First-time treatment with steroids in bronchial asthma: comparison of the effects of inhaled beclomethasone and of oral prednisone on airway function, bronchial reactivity and hypothalamic-pituitary-adrenal axis. Eur Respir J.1990;3:786\u2013791","DOI":"10.1183\/09031936.93.03070786"},{"key":"2021121010094566300_R11","doi-asserted-by":"crossref","unstructured":"Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol.1987;80:81\u201387","DOI":"10.1016\/S0091-6749(87)80195-1"},{"key":"2021121010094566300_R12","doi-asserted-by":"crossref","unstructured":"American Thoracic Society. Guidelines to the diagnosis and treatment of asthma. Am Rev Respir Dis.1987;136:225\u2013244","DOI":"10.1164\/ajrccm\/136.1.225"},{"key":"2021121010094566300_R13","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child.1970;45:13\u201323","DOI":"10.1136\/adc.45.239.13"},{"key":"2021121010094566300_R14","doi-asserted-by":"crossref","unstructured":"Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child.1969;44:291\u2013303","DOI":"10.1136\/adc.44.235.291"},{"key":"2021121010094566300_R15","doi-asserted-by":"crossref","unstructured":"Ducharme FM, Davis GM. Measurement of respiratory resistance in the emergency department: feasibility in young children with acute asthma. Chest.1997;111:1519\u20131525","DOI":"10.1378\/chest.111.6.1519"},{"key":"2021121010094566300_R16","doi-asserted-by":"crossref","unstructured":"Ducharme FM, Davis GM, Ducharme GR. Pediatric reference values for respiratory resistance measured by forced oscillation. Chest.1998;113:1322\u20131328","DOI":"10.1378\/chest.113.5.1322"},{"key":"2021121010094566300_R17","doi-asserted-by":"crossref","unstructured":"Buster JE, Abraham GE. Radioimmunoassay of plasma dehydroepiandrosterone sulphate. Anal Lett.1972;5:543\u2013551","DOI":"10.1080\/00032717208062119"},{"key":"2021121010094566300_R18","doi-asserted-by":"crossref","unstructured":"de Peretti E, Forest MG. Pattern of plasma dehydroepiandrosterone sulfate levels in humans from birth to adulthood: evidence for testicular production. J Clin Endocrinol Metab.1978;47:572\u2013577","DOI":"10.1210\/jcem-47-3-572"},{"key":"2021121010094566300_R19","doi-asserted-by":"crossref","unstructured":"Walton RJ, Bijvoet OLM. Nomogram for derivation of renal threshold phosphate concentration. Lancet.1975;2:309\u2013310","DOI":"10.1016\/S0140-6736(75)92736-1"},{"key":"2021121010094566300_R20","doi-asserted-by":"crossref","unstructured":"Hanson DA, Weis MAE, Bollen AM, Shoshana LM, Singer FR, Eyre DR. A Specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked n-telopeptides in urine. J Bone Miner Res.1992;7:1251\u20131258","DOI":"10.1002\/jbmr.5650071119"},{"key":"2021121010094566300_R21","doi-asserted-by":"crossref","unstructured":"Helfer EL, Rose LI. Corticosteroids and adrenal suppression. Characterising and avoiding the problem. Drugs.1989;38:838\u2013845","DOI":"10.2165\/00003495-198938050-00008"},{"key":"2021121010094566300_R22","doi-asserted-by":"crossref","unstructured":"Wolthers OD, Honour JW. Measures of hypothalamic-pituitary-adrenal function in patients with asthma treated with inhaled glucocorticoids: clinical and research implications. J Asthma.1999;36:477\u2013486","DOI":"10.3109\/02770909909054553"},{"key":"2021121010094566300_R23","doi-asserted-by":"crossref","unstructured":"Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA.1983;249:1743\u20131745","DOI":"10.1001\/jama.249.13.1743"},{"key":"2021121010094566300_R24","doi-asserted-by":"crossref","unstructured":"Santner TJ, Snell MK. Small sample confidence interval for p1\u2013p2 and p1\/p2 in 2 x 2 contingency tables. J Am Stat Assoc.1980;75:386\u2013394","DOI":"10.1080\/01621459.1980.10477482"},{"key":"2021121010094566300_R25","unstructured":"Rothman KJ. Analysis With Multiple Levels of Exposure. In: Modern Epidemiology. Boston, MA: Little, Brown, and Co; 1986:327\u2013349"},{"key":"2021121010094566300_R26","doi-asserted-by":"crossref","unstructured":"Bollen AM, Martin MD, Leroux BG, Eyre DR. Circadian variation in urinary excretion of bone collagen cross-links. J Bone Miner Res.1995;10:1885\u20131890","DOI":"10.1002\/jbmr.5650101207"},{"key":"2021121010094566300_R27","doi-asserted-by":"crossref","unstructured":"Bollen AM, Eyre DR. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone.1994;15:31\u201334","DOI":"10.1016\/8756-3282(94)90888-5"},{"key":"2021121010094566300_R28","doi-asserted-by":"crossref","unstructured":"Price JF. Inhaled corticosteroids: clinical relevance of safety measures. Pediatr Pulmonol Suppl.1997;15:40\u201345","DOI":"10.1002\/(SICI)1099-0496(199709)15+<40::AID-PPUL9>3.0.CO;2-V"},{"key":"2021121010094566300_R29","doi-asserted-by":"crossref","unstructured":"Wilson AM, McFarlane LC, Lipworth BJ. Systemic bioactivity profiles of oral prednisolone and nebulized budesonide in adult asthmatics. Chest.1998;114:1022\u20131027","DOI":"10.1378\/chest.114.4.1022"},{"key":"2021121010094566300_R30","doi-asserted-by":"crossref","unstructured":"Boulet LP, Giguere MC, Milot J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol.1994;94:796\u2013803","DOI":"10.1016\/0091-6749(94)90145-7"},{"key":"2021121010094566300_R31","doi-asserted-by":"crossref","unstructured":"Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J.1996;312:1254\u20131259","DOI":"10.1136\/bmj.312.7041.1254"},{"key":"2021121010094566300_R32","doi-asserted-by":"crossref","unstructured":"Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med.1999;159:941\u2013955","DOI":"10.1001\/archinte.159.9.941"},{"key":"2021121010094566300_R33","doi-asserted-by":"crossref","unstructured":"Boot AM, de Ridder MA, Pols HA, Krenning EP, de Muinck Keizer-Schrama SMPF. Bone mineral density in children and adolescents: relation to puberty, calcium intake, and physical activity. J Clin Endocrinol Metab.1997;82:57\u201362","DOI":"10.1210\/jc.82.1.57"},{"key":"2021121010094566300_R34","doi-asserted-by":"crossref","unstructured":"Kinberg KA, Hopp RJ, Biven RE, Gallagher JC. Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol.1994;94(3 Pt 1):490\u2013497","DOI":"10.1016\/0091-6749(94)90205-4"},{"key":"2021121010094566300_R35","doi-asserted-by":"crossref","unstructured":"Konig P, Hillman L, Cervantes C, et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr.1993;122:219\u2013226","DOI":"10.1016\/S0022-3476(06)80116-2"},{"key":"2021121010094566300_R36","doi-asserted-by":"crossref","unstructured":"Efthimiou J, Barnes PJ. Effect of inhaled corticosteroids on bones and growth. Eur Respir J.1998;11:1167\u20131177","DOI":"10.1183\/09031936.98.11051167"},{"key":"2021121010094566300_R37","doi-asserted-by":"crossref","unstructured":"Zora JA, Zimmerman D, Carey TL, O\u2019Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol.1986;77:9\u201313","DOI":"10.1016\/0091-6749(86)90315-5"},{"key":"2021121010094566300_R38","doi-asserted-by":"crossref","unstructured":"Clayton RN. Diagnosis of adrenal insufficiency. Br Med J.1989;298:271\u2013272","DOI":"10.1136\/bmj.298.6669.271"},{"key":"2021121010094566300_R39","doi-asserted-by":"crossref","unstructured":"Zimmerman B, Wherrett D. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate. J Allergy Clin Immunol.1998;101:425\u2013426","DOI":"10.1016\/S0091-6749(98)70260-X"},{"key":"2021121010094566300_R40","doi-asserted-by":"crossref","unstructured":"Price JF. Asthma, growth and inhaled corticosteroids. Respir Med.1993;87(suppl A):23\u201326","DOI":"10.1016\/S0954-6111(05)80253-7"},{"key":"2021121010094566300_R41","doi-asserted-by":"crossref","unstructured":"Kasper WJ, Howe PM. Fatal varicella after a single course of corticosteroids. Pediatr Infect Dis J.1990;9:729\u2013732","DOI":"10.1097\/00006454-199010000-00009"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/2\/376\/1007710\/pe0203000376.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/2\/376\/1007710\/pe0203000376.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:45:02Z","timestamp":1682747102000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/2\/376\/66768\/Safety-Profile-of-Frequent-Short-Courses-of-Oral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2003,2,1]]},"published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.2.376","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}